公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2016 | Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials | Wang L.-T; Ting C.-H; MEN-LUH YEN ; Liu K.-J; Sytwu H.-K; Wu K.K; Yen B.L. | Journal of Biomedical Science | 250 | 126 | |
2011 | Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells | Chen P.-M; MEN-LUH YEN ; Liu K.-J; Sytwu H.-K; Yen B.-L. | Journal of Biomedical Science | 137 | 121 | |
2015 | Interleukin-25 Mediates Transcriptional Control of PD-L1 via STAT3 in Multipotent Human Mesenchymal Stromal Cells (hMSCs) to Suppress Th17 Responses | Wang W.-B; MEN-LUH YEN ; Liu K.-J; Hsu P.-J; Lin M.-H; Chen P.-M; Sudhir P.-R; Chen C.-H; Chen C.-H; Sytwu H.-K; Yen B.L. | Stem Cell Reports | 59 | 52 | |
2013 | Multipotent human mesenchymal stromal cells mediate expansion of myeloid-derived suppressor cells via hepatocyte growth factor/c-Met and STAT3 | Yen B.L; MEN-LUH YEN ; Hsu P.-J; Liu K.-J; Wang C.-J; Bai C.-H; Sytwu H.-K. | Stem Cell Reports | 108 | 104 |